Literature DB >> 17531731

Efficacy of ropivacaine, bupivacaine, and levobupivacaine for labor epidural analgesia.

Neera Sah1, Manuel Vallejo, Amy Phelps, Helene Finegold, Gordon Mandell, Sivam Ramanathan.   

Abstract

STUDY
OBJECTIVE: To compare analgesic efficacy and intensity of motor block with continuous infusions of ropivacaine, bupivacaine, and levobupivacaine in combination with fentanyl for labor epidural analgesia.
DESIGN: Prospective, randomized, double-blinded study.
SETTING: Labor and delivery suite at Magee Womens Hospital, Pittsburgh, PA. PATIENTS: 162 ASA physical status I and II, full-term, primiparous women.
INTERVENTIONS: All patients received epidural labor analgesia. Epidural medication consisted of an initial bolus of 8 mL local anesthetic with fentanyl (100 microg) followed by an infusion at 12 mL/h of local anesthetic with 2 microg/mL fentanyl. Patients were allocated to one of three groups, as follows: group 1 received bolus and infusion of bupivacaine 0.125%, group 2 received bolus and infusion of levobupivacaine 0.125%, and group 3 received a bolus of ropivacaine 0.2% and infusion of ropivacaine 0.1%. MEASUREMENTS: Maternal vital signs, pain visual analog scale (VAS) score, sensory levels, and motor block (Bromage score) were recorded every hour. Duration of first and second stage of labor and mode of delivery were also recorded.
RESULTS: There were no statistically significant differences in pain VAS or Bromage motor scores among the three groups of patients at any of the measured time intervals. The time to achieve T10 sensory level and patient comfort was shorter in the ropivacaine (9.35 +/- 4.96 min) and levobupivacaine (9.56 +/- 4.71 min) groups than the bupivacaine (11.89 +/- 7.76 min) group, although this difference did not reach a statistically significant level (P = 0.06). The second stage was significantly shorter in the bupivacaine group, lasting 81.27 +/- 63.3 min, compared with the ropivacaine group (121.69 +/- 86.5 min) and the levobupivacaine (115.5 +/- 83.6 minutes) group (P = 0.04).
CONCLUSION: There are no significant differences in pain VAS and Bromage scores between 0.1% ropivacaine, 0.125% bupivacaine, and 0.1% levobupivacaine given for labor epidural analgesia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531731     DOI: 10.1016/j.jclinane.2006.11.003

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  5 in total

Review 1.  Levobupivacaine: a review of its use in regional anaesthesia and pain management.

Authors:  Mark Sanford; Gillian M Keating
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

2.  Quality of Labor Epidural Analgesia and Maternal Outcome With Levobupivacaine and Ropivacaine: A Double-Blinded Randomized Trial.

Authors:  T Senthil Kumar; P Rani; V R Hemanth Kumar; Sunita Samal; S Parthasarathy; M Ravishankar
Journal:  Anesth Essays Res       Date:  2017 Jan-Mar

3.  Comparison of Three Different Concentrations of Levobupivacaine for Epidural Labor Analgesia: Clinical Effect and Pharmacokinetic Profile.

Authors:  Ahmed Mostafa El-Shaarawy; Mohamed S Asfour; Doaa A Rashwan; Mahmoud M Amer; Shahira F El-Menshawe; Mohammed H Elkomy
Journal:  Anesth Essays Res       Date:  2018 Jan-Mar

4.  Effects of Ropivacaine in Patient-Controlled Epidural Analgesia on Uterine Electromyographic Activities during Labor.

Authors:  Xueya Qian; Qingning Wang; Xinxu Ou; Pin Li; Baisong Zhao; Huishu Liu
Journal:  Biomed Res Int       Date:  2018-11-07       Impact factor: 3.411

5.  Effect of caudal bupivacaine alone and with adjuvant fentanyl and nalbuphine to minimize the catheter-related bladder discomfort after tubeless percutaneous nephrolithotomy: A prospective randomized study.

Authors:  Dinesh J Prajapati; Manoj Patel; Pankaj Patel; Mohankumar Vijayakumar; Arvind Ganpule; Deepak Mistry
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.